APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhalation Anesthetic

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Inhalation Anesthetic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025198 pages

Choose your research edition.

Industry ResearchInhalation Anesthetic Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalation Anesthetic Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Inhalation Anesthetic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalation Anesthetic Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalation Anesthetic Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Inhalation Anesthetic market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Inhalation Anesthetic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Inhalation Anesthetic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhalation Anesthetic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Inhalation Anesthetic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Inhalation Anesthetic include Mylan, Hengrui, Baxter Healthcare, AstraZeneca, Piramal Healthcare, Nhwa, Maruishi, Lunan and Hikma Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Inhalation Anesthetic market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Inhalation Anesthetic and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Inhalation Anesthetic sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Inhalation Anesthetic market size, projected growth trends, production technologies, key applications, and end-use industries.

Inhalation Anesthetic Segment by Company

Mylan

Hengrui

Baxter Healthcare

AstraZeneca

Piramal Healthcare

Nhwa

Maruishi

Lunan

Hikma Pharmaceuticals

Fresenius-Kabi

Deltasorb Technologies (Blue Zone Technology)

Braun

BbVie Laboratories

Anesthesia Reclamation

Inhalation Anesthetic Segment by Type

Desflurane

Sevoflurane

Isoflurane

Others

Inhalation Anesthetic Segment by Application

Hospital Use

Clinic Use

Inhalation Anesthetic Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation Anesthetic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalation Anesthetic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation Anesthetic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Inhalation Anesthetic market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Inhalation Anesthetic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Inhalation Anesthetic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Inhalation Anesthetic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Inhalation Anesthetic Industry Trends Table 2. Inhalation Anesthetic Industry Drivers Table 3. Inhalation Anesthetic Industry Opportunities and Challenges Table 4. Inhalation Anesthetic Industry Restraints Table 5. Global Inhalation Anesthetic Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Inhalation Anesthetic Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Inhalation Anesthetic Sales by Manufacturers (W Tons) & (2021-2026) Table 8. Global Inhalation Anesthetic Sales Market Share by Manufacturers Table 9. Global Inhalation Anesthetic Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Inhalation Anesthetic Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Inhalation Anesthetic Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Inhalation Anesthetic Manufacturers, Product Type & Application Table 13. Global Inhalation Anesthetic Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Inhalation Anesthetic by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Desflurane Table 17. Major Manufacturers of Sevoflurane Table 18. Major Manufacturers of Isoflurane Table 19. Major Manufacturers of Others Table 20. Global Inhalation Anesthetic Sales by Type 2021 VS 2025 VS 2032 (W Tons) Table 21. Global Inhalation Anesthetic Sales by Type (2021-2026) & (W Tons) Table 22. Global Inhalation Anesthetic Sales by Type (2027-2032) & (W Tons) Table 23. Global Inhalation Anesthetic Sales Market Share by Type (2021-2026) Table 24. Global Inhalation Anesthetic Sales Market Share by Type (2027-2032) Table 25. Global Inhalation Anesthetic Revenue by Type 2021 VS 2025 VS 2032 (W Tons) Table 26. Global Inhalation Anesthetic Revenue by Type (2021-2026) & (W Tons) Table 27. Global Inhalation Anesthetic Revenue by Type (2027-2032) & (W Tons) Table 28. Global Inhalation Anesthetic Revenue Market Share by Type (2021-2026) Table 29. Global Inhalation Anesthetic Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Use Table 31. Major Manufacturers of Clinic Use Table 32. Global Inhalation Anesthetic Sales by Application 2021 VS 2025 VS 2032 (W Tons) Table 33. Global Inhalation Anesthetic Sales by Application (2021-2026) & (W Tons) Table 34. Global Inhalation Anesthetic Sales by Application (2027-2032) & (W Tons) Table 35. Global Inhalation Anesthetic Sales Market Share by Application (2021-2026) Table 36. Global Inhalation Anesthetic Sales Market Share by Application (2027-2032) Table 37. Global Inhalation Anesthetic Revenue by Application 2021 VS 2025 VS 2032 (W Tons) Table 38. Global Inhalation Anesthetic Revenue by Application (2021-2026) & (W Tons) Table 39. Global Inhalation Anesthetic Revenue by Application (2027-2032) & (W Tons) Table 40. Global Inhalation Anesthetic Revenue Market Share by Application (2021-2026) Table 41. Global Inhalation Anesthetic Revenue Market Share by Application (2027-2032) Table 42. Global Inhalation Anesthetic Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Table 43. Global Inhalation Anesthetic Sales by Region (2021-2026) & (W Tons) Table 44. Global Inhalation Anesthetic Sales Market Share by Region (2021-2026) Table 45. Global Inhalation Anesthetic Sales Forecasted by Region (2027-2032) & (W Tons) Table 46. Global Inhalation Anesthetic Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Inhalation Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 48. North America Inhalation Anesthetic Sales by Country (2021-2026) & (W Tons) Table 49. North America Inhalation Anesthetic Sales by Country (2027-2032) & (W Tons) Table 50. Europe Inhalation Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 51. Europe Inhalation Anesthetic Sales by Country (2021-2026) & (W Tons) Table 52. Europe Inhalation Anesthetic Sales by Country (2027-2032) & (W Tons) Table 53. Asia Pacific Inhalation Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 54. Asia Pacific Inhalation Anesthetic Sales by Country (2021-2026) & (W Tons) Table 55. Asia Pacific Inhalation Anesthetic Sales by Country (2027-2032) & (W Tons) Table 56. South America, Middle East and Africa Inhalation Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 57. South America, Middle East and Africa Inhalation Anesthetic Sales by Country (2021-2026) & (W Tons) Table 58. South America, Middle East and Africa Inhalation Anesthetic Sales by Country (2027-2032) & (W Tons) Table 59. Global Inhalation Anesthetic Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Inhalation Anesthetic Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Inhalation Anesthetic Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Inhalation Anesthetic Revenue Market Share by Region (2021-2026) Table 63. Global Inhalation Anesthetic Revenue Market Share by Region (2027-2032) Table 64. Mylan Company Information Table 65. Mylan Business Overview Table 66. Mylan Inhalation Anesthetic Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Mylan Inhalation Anesthetic Product Portfolio Table 68. Mylan Recent Development Table 69. Hengrui Company Information Table 70. Hengrui Business Overview Table 71. Hengrui Inhalation Anesthetic Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Hengrui Inhalation Anesthetic Product Portfolio Table 73. Hengrui Recent Development Table 74. Baxter Healthcare Company Information Table 75. Baxter Healthcare Business Overview Table 76. Baxter Healthcare Inhalation Anesthetic Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Baxter Healthcare Inhalation Anesthetic Product Portfolio Table 78. Baxter Healthcare Recent Development Table 79. AstraZeneca Company Information Table 80. AstraZeneca Business Overview Table 81. AstraZeneca Inhalation Anesthetic Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. AstraZeneca Inhalation Anesthetic Product Portfolio Table 83. AstraZeneca Recent Development Table 84. Piramal Healthcare Company Information Table 85. Piramal Healthcare Business Overview Table 86. Piramal Healthcare Inhalation Anesthetic Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Piramal Healthcare Inhalation Anesthetic Product Portfolio Table 88. Piramal Healthcare Recent Development Table 89. Nhwa Company Information Table 90. Nhwa Business Overview Table 91. Nhwa Inhalation Anesthetic Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Nhwa Inhalation Anesthetic Product Portfolio Table 93. Nhwa Recent Development Table 94. Maruishi Company Information Table 95. Maruishi Business Overview Table 96. Maruishi Inhalation Anesthetic Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Maruishi Inhalation Anesthetic Product Portfolio Table 98. Maruishi Recent Development Table 99. Lunan Company Information Table 100. Lunan Business Overview Table 101. Lunan Inhalation Anesthetic Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Lunan Inhalation Anesthetic Product Portfolio Table 103. Lunan Recent Development Table 104. Hikma Pharmaceuticals Company Information Table 105. Hikma Pharmaceuticals Business Overview Table 106. Hikma Pharmaceuticals Inhalation Anesthetic Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Hikma Pharmaceuticals Inhalation Anesthetic Product Portfolio Table 108. Hikma Pharmaceuticals Recent Development Table 109. Fresenius-Kabi Company Information Table 110. Fresenius-Kabi Business Overview Table 111. Fresenius-Kabi Inhalation Anesthetic Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Fresenius-Kabi Inhalation Anesthetic Product Portfolio Table 113. Fresenius-Kabi Recent Development Table 114. Deltasorb Technologies (Blue Zone Technology) Company Information Table 115. Deltasorb Technologies (Blue Zone Technology) Business Overview Table 116. Deltasorb Technologies (Blue Zone Technology) Inhalation Anesthetic Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Deltasorb Technologies (Blue Zone Technology) Inhalation Anesthetic Product Portfolio Table 118. Deltasorb Technologies (Blue Zone Technology) Recent Development Table 119. Braun Company Information Table 120. Braun Business Overview Table 121. Braun Inhalation Anesthetic Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Braun Inhalation Anesthetic Product Portfolio Table 123. Braun Recent Development Table 124. BbVie Laboratories Company Information Table 125. BbVie Laboratories Business Overview Table 126. BbVie Laboratories Inhalation Anesthetic Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. BbVie Laboratories Inhalation Anesthetic Product Portfolio Table 128. BbVie Laboratories Recent Development Table 129. Anesthesia Reclamation Company Information Table 130. Anesthesia Reclamation Business Overview Table 131. Anesthesia Reclamation Inhalation Anesthetic Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Anesthesia Reclamation Inhalation Anesthetic Product Portfolio Table 133. Anesthesia Reclamation Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Inhalation Anesthetic Distributors List Table 137. Inhalation Anesthetic Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Inhalation Anesthetic Product Image Figure 2. Global Inhalation Anesthetic Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhalation Anesthetic Market Size (2021-2032) & (US$ Million) Figure 4. Global Inhalation Anesthetic Sales (2021-2032) & (W Tons) Figure 5. Global Inhalation Anesthetic Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Inhalation Anesthetic Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Desflurane Image Figure 9. Sevoflurane Image Figure 10. Isoflurane Image Figure 11. Others Image Figure 12. Global Inhalation Anesthetic Sales by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 13. Global Inhalation Anesthetic Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Inhalation Anesthetic Sales Market Share by Type (2021-2032) Figure 15. Global Inhalation Anesthetic Revenue by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 16. Global Inhalation Anesthetic Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Inhalation Anesthetic Revenue Market Share by Type (2021-2032) Figure 18. Hospital Use Image Figure 19. Clinic Use Image Figure 20. Global Inhalation Anesthetic Sales by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 21. Global Inhalation Anesthetic Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Inhalation Anesthetic Sales Market Share by Application (2021-2032) Figure 23. Global Inhalation Anesthetic Revenue by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 24. Global Inhalation Anesthetic Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Inhalation Anesthetic Revenue Market Share by Application (2021-2032) Figure 26. North America Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 27. North America Inhalation Anesthetic Sales Market Share by Country (2021-2032) Figure 28. U.S. Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 29. Canada Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 30. Mexico Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 31. Europe Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 32. Europe Inhalation Anesthetic Sales Market Share by Country (2021-2032) Figure 33. Germany Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 34. France Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 35. U.K. Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 36. Italy Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 37. Netherlands Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 38. Asia Pacific Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 39. Asia Pacific Inhalation Anesthetic Sales Market Share by Country (2021-2032) Figure 40. China Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 41. Japan Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 42. South Korea Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 43. Southeast Asia Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 44. India Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 45. Australia Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 46. South America, Middle East and Africa Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 47. South America, Middle East and Africa Inhalation Anesthetic Sales Market Share by Country (2021-2032) Figure 48. Brazil Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 49. South Africa Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 50. Saudi Arabia Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 51. Turkey Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 52. Argentina Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 53. UAE Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 54. Egypt Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 55. Chile Inhalation Anesthetic Sales and Growth Rate (2021-2032) & (W Tons) Figure 56. Global Inhalation Anesthetic Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Inhalation Anesthetic Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Inhalation Anesthetic Revenue (2021-2032) & (US$ Million) Figure 59. North America Inhalation Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Inhalation Anesthetic Revenue (2021-2032) & (US$ Million) Figure 61. Europe Inhalation Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Inhalation Anesthetic Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Inhalation Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Inhalation Anesthetic Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Inhalation Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Inhalation Anesthetic Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Inhalation Anesthetic Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Desflurane
  • Sevoflurane
  • Isoflurane
  • Others
Applications
  • Hospital Use
  • Clinic Use
Companies covered
  • Mylan
  • Hengrui
  • Baxter Healthcare
  • AstraZeneca
  • Piramal Healthcare
  • Nhwa
  • Maruishi
  • Lunan
  • Hikma Pharmaceuticals
  • Fresenius-Kabi
  • Deltasorb Technologies (Blue Zone Technology)
  • Braun
  • BbVie Laboratories
  • Anesthesia Reclamation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Inhalation Anesthetic Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Inhalation Anesthetic Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Inhalation Anesthetic Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Inhalation Anesthetic Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Inhalation Anesthetic Market Dynamics
  1. 2.1 Inhalation Anesthetic Industry Trends
  2. 2.2 Inhalation Anesthetic Industry Drivers
  3. 2.3 Inhalation Anesthetic Industry Opportunities and Challenges
  4. 2.4 Inhalation Anesthetic Industry Restraints
3 Inhalation Anesthetic Market by Manufacturers
  1. 3.1 Global Inhalation Anesthetic Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Inhalation Anesthetic Sales by Manufacturers (2021-2026)
  3. 3.3 Global Inhalation Anesthetic Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Inhalation Anesthetic Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Inhalation Anesthetic Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Inhalation Anesthetic Manufacturers, Product Type & Application
  7. 3.7 Global Inhalation Anesthetic Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Inhalation Anesthetic Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Inhalation Anesthetic Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Inhalation Anesthetic Tier 1, Tier 2, and Tier 3
4 Inhalation Anesthetic Market by Type
  1. 4.1 Inhalation Anesthetic Type Introduction
  2. 4.1.1 Desflurane
  3. 4.1.2 Sevoflurane
  4. 4.1.3 Isoflurane
  5. 4.1.4 Others
  6. 4.2 Global Inhalation Anesthetic Sales by Type
  7. 4.2.1 Global Inhalation Anesthetic Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Inhalation Anesthetic Sales by Type (2021-2032)
  9. 4.2.3 Global Inhalation Anesthetic Sales Market Share by Type (2021-2032)
  10. 4.3 Global Inhalation Anesthetic Revenue by Type
  11. 4.3.1 Global Inhalation Anesthetic Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Inhalation Anesthetic Revenue by Type (2021-2032)
  13. 4.3.3 Global Inhalation Anesthetic Revenue Market Share by Type (2021-2032)
5 Inhalation Anesthetic Market by Application
  1. 5.1 Inhalation Anesthetic Application Introduction
  2. 5.1.1 Hospital Use
  3. 5.1.2 Clinic Use
  4. 5.2 Global Inhalation Anesthetic Sales by Application
  5. 5.2.1 Global Inhalation Anesthetic Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Inhalation Anesthetic Sales by Application (2021-2032)
  7. 5.2.3 Global Inhalation Anesthetic Sales Market Share by Application (2021-2032)
  8. 5.3 Global Inhalation Anesthetic Revenue by Application
  9. 5.3.1 Global Inhalation Anesthetic Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Inhalation Anesthetic Revenue by Application (2021-2032)
  11. 5.3.3 Global Inhalation Anesthetic Revenue Market Share by Application (2021-2032)
6 Global Inhalation Anesthetic Sales by Region
  1. 6.1 Global Inhalation Anesthetic Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Inhalation Anesthetic Sales by Region (2021-2032)
  3. 6.2.1 Global Inhalation Anesthetic Sales by Region (2021-2026)
  4. 6.2.2 Global Inhalation Anesthetic Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Inhalation Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Inhalation Anesthetic Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Inhalation Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Inhalation Anesthetic Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Inhalation Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Inhalation Anesthetic Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Inhalation Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Inhalation Anesthetic Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Inhalation Anesthetic Revenue by Region
  1. 7.1 Global Inhalation Anesthetic Revenue by Region
  2. 7.1.1 Global Inhalation Anesthetic Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Inhalation Anesthetic Revenue by Region (2021-2026)
  4. 7.1.3 Global Inhalation Anesthetic Revenue by Region (2027-2032)
  5. 7.1.4 Global Inhalation Anesthetic Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Inhalation Anesthetic Revenue (2021-2032)
  8. 7.2.2 North America Inhalation Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Inhalation Anesthetic Revenue (2021-2032)
  11. 7.3.2 Europe Inhalation Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Inhalation Anesthetic Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Inhalation Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Inhalation Anesthetic Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Inhalation Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Mylan
  2. 8.1.1 Mylan Company Information
  3. 8.1.2 Mylan Business Overview
  4. 8.1.3 Mylan Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Mylan Inhalation Anesthetic Product Portfolio
  6. 8.1.5 Mylan Recent Developments
  7. 8.2 Hengrui
  8. 8.2.1 Hengrui Company Information
  9. 8.2.2 Hengrui Business Overview
  10. 8.2.3 Hengrui Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hengrui Inhalation Anesthetic Product Portfolio
  12. 8.2.5 Hengrui Recent Developments
  13. 8.3 Baxter Healthcare
  14. 8.3.1 Baxter Healthcare Company Information
  15. 8.3.2 Baxter Healthcare Business Overview
  16. 8.3.3 Baxter Healthcare Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Baxter Healthcare Inhalation Anesthetic Product Portfolio
  18. 8.3.5 Baxter Healthcare Recent Developments
  19. 8.4 AstraZeneca
  20. 8.4.1 AstraZeneca Company Information
  21. 8.4.2 AstraZeneca Business Overview
  22. 8.4.3 AstraZeneca Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca Inhalation Anesthetic Product Portfolio
  24. 8.4.5 AstraZeneca Recent Developments
  25. 8.5 Piramal Healthcare
  26. 8.5.1 Piramal Healthcare Company Information
  27. 8.5.2 Piramal Healthcare Business Overview
  28. 8.5.3 Piramal Healthcare Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Piramal Healthcare Inhalation Anesthetic Product Portfolio
  30. 8.5.5 Piramal Healthcare Recent Developments
  31. 8.6 Nhwa
  32. 8.6.1 Nhwa Company Information
  33. 8.6.2 Nhwa Business Overview
  34. 8.6.3 Nhwa Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Nhwa Inhalation Anesthetic Product Portfolio
  36. 8.6.5 Nhwa Recent Developments
  37. 8.7 Maruishi
  38. 8.7.1 Maruishi Company Information
  39. 8.7.2 Maruishi Business Overview
  40. 8.7.3 Maruishi Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Maruishi Inhalation Anesthetic Product Portfolio
  42. 8.7.5 Maruishi Recent Developments
  43. 8.8 Lunan
  44. 8.8.1 Lunan Company Information
  45. 8.8.2 Lunan Business Overview
  46. 8.8.3 Lunan Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lunan Inhalation Anesthetic Product Portfolio
  48. 8.8.5 Lunan Recent Developments
  49. 8.9 Hikma Pharmaceuticals
  50. 8.9.1 Hikma Pharmaceuticals Company Information
  51. 8.9.2 Hikma Pharmaceuticals Business Overview
  52. 8.9.3 Hikma Pharmaceuticals Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hikma Pharmaceuticals Inhalation Anesthetic Product Portfolio
  54. 8.9.5 Hikma Pharmaceuticals Recent Developments
  55. 8.10 Fresenius-Kabi
  56. 8.10.1 Fresenius-Kabi Company Information
  57. 8.10.2 Fresenius-Kabi Business Overview
  58. 8.10.3 Fresenius-Kabi Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Fresenius-Kabi Inhalation Anesthetic Product Portfolio
  60. 8.10.5 Fresenius-Kabi Recent Developments
  61. 8.11 Deltasorb Technologies (Blue Zone Technology)
  62. 8.11.1 Deltasorb Technologies (Blue Zone Technology) Company Information
  63. 8.11.2 Deltasorb Technologies (Blue Zone Technology) Business Overview
  64. 8.11.3 Deltasorb Technologies (Blue Zone Technology) Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Deltasorb Technologies (Blue Zone Technology) Inhalation Anesthetic Product Portfolio
  66. 8.11.5 Deltasorb Technologies (Blue Zone Technology) Recent Developments
  67. 8.12 Braun
  68. 8.12.1 Braun Company Information
  69. 8.12.2 Braun Business Overview
  70. 8.12.3 Braun Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Braun Inhalation Anesthetic Product Portfolio
  72. 8.12.5 Braun Recent Developments
  73. 8.13 BbVie Laboratories
  74. 8.13.1 BbVie Laboratories Company Information
  75. 8.13.2 BbVie Laboratories Business Overview
  76. 8.13.3 BbVie Laboratories Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 BbVie Laboratories Inhalation Anesthetic Product Portfolio
  78. 8.13.5 BbVie Laboratories Recent Developments
  79. 8.14 Anesthesia Reclamation
  80. 8.14.1 Anesthesia Reclamation Company Information
  81. 8.14.2 Anesthesia Reclamation Business Overview
  82. 8.14.3 Anesthesia Reclamation Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Anesthesia Reclamation Inhalation Anesthetic Product Portfolio
  84. 8.14.5 Anesthesia Reclamation Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Inhalation Anesthetic Value Chain Analysis
  2. 9.1.1 Inhalation Anesthetic Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Inhalation Anesthetic Production Mode & Process
  6. 9.2 Inhalation Anesthetic Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Inhalation Anesthetic Distributors
  9. 9.2.3 Inhalation Anesthetic Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst